Illumina (ILMN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

ILMN Stock Forecast

Illumina stock forecast is as follows: an average price target of $202.44 (represents a 54.84% upside from ILMN’s last price of $130.74) and a rating consensus of 'Buy', based on 22 wall street analysts offering a 1-year stock forecast.

ILMN Price Target

The average price target for Illumina (ILMN) is $202.44 based on 1-year price targets from 22 Wall Street analysts in the past 3 months, with a price target range of $562.00 to $58.00. This represents a potential 54.84% upside from ILMN's last price of $130.74.

ILMN Analyst Ratings

Buy

According to 22 Wall Street analysts, Illumina's rating consensus is 'Buy'. The analyst rating breakdown for ILMN stock is 0 'Strong Buy' (0.00%), 16 'Buy' (72.73%), 5 'Hold' (22.73%), 1 'Sell' (4.55%), and 0 'Strong Sell' (0.00%).

Illumina Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 06, 2024	Catherine Ramsey Schulte	Robert W. Baird	$139.00	$156.21	-11.02%	6.32%
Nov 05, 2024	Kyle Mikson	Canaccord Genuity	$145.00	$156.21	-7.18%	10.91%
Nov 05, 2024	Luke Sergott	Barclays	$145.00	$156.21	-7.18%	10.91%
Oct 17, 2024	Shubhangi Gupta	HSBC	$180.00	$143.89	25.10%	37.68%
Aug 28, 2024	Jasper Hellweg	Argus Research	$150.00	$131.46	14.10%	14.73%
Aug 16, 2024	Narumi Nakagiri	Daiwa	$154.00	$130.04	18.43%	17.79%
Aug 15, 2024	Sung Ji Nam	Scotiabank	$164.00	$127.33	28.80%	25.44%
Aug 14, 2024	Luke Sergott	Barclays	$125.00	$123.58	1.15%	-4.39%
Aug 14, 2024	Nick Setyan	Wedbush	$58.00	$123.58	-53.07%	-55.64%
Aug 13, 2024	David Westenberg	Piper Sandler	$195.00	$124.54	56.58%	49.15%

Row per page

Go to

The latest Illumina stock forecast, released on Nov 06, 2024 by Catherine Ramsey Schulte from Robert W. Baird, set a price target of $139.00, which represents a -11.02% decrease from the stock price at the time of the forecast ($156.21), and a 6.32% increase from ILMN last price ($130.74).

Illumina Price Target by Period

	1M	3M	12M
# Anlaysts	3	5	18
Avg Price Target	$143.00	$151.80	$149.61
Last Closing Price	$130.74	$130.74	$130.74
Upside/Downside	9.38%	16.11%	14.43%

In the current month, the average price target of Illumina stock is $143.00, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 9.38% increase as opposed to Illumina's last price of $130.74. This month's average price target is down -5.80% compared to last quarter, and down -4.42% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 05, 2024	Canaccord Genuity	Hold	Hold	Hold
Nov 05, 2024	Barclays	Positive	Positive	Hold
Oct 17, 2024	HSBC	-	Buy	Upgrade
Oct 15, 2024	Barclays	Equal-Weight	Equal-Weight	Hold
Oct 10, 2024	UBS	Buy	Buy	Hold
Oct 02, 2024	RBC Capital	Outperform	Outperform	Hold
Aug 16, 2024	Benchmark	Buy	Buy	Hold
Aug 16, 2024	Daiwa	-	Buy	Upgrade
Aug 15, 2024	Scotiabank	Sector Outperform	Sector Outperform	Hold
Aug 14, 2024	Wedbush	Neutral	Outperform	Upgrade

Row per page

Go to

Illumina's last stock rating was published by Canaccord Genuity on Nov 05, 2024. The company gave ILMN a "Hold" rating, the same as its previous rate.

Illumina Financial Forecast

Illumina Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.12B	-	$1.18B	$1.09B	$1.20B	$1.11B	$1.16B	$1.22B	$953.00M	$1.11B	$1.13B	$1.09B	-	$794.00M
Avg Forecast	$1.29B	$1.29B	$1.26B	$1.24B	$1.20B	$1.19B	$1.17B	$1.13B	$1.16B	$1.13B	$1.12B	$1.08B	$1.07B	$1.08B	$1.09B	$1.05B	$1.09B	$1.13B	$1.16B	$1.07B	$1.07B	$1.11B	$1.22B	$1.22B	$1.13B	$1.05B	$1.02B	$996.34M	$903.91M	$715.83M
High Forecast	$1.32B	$1.31B	$1.28B	$1.27B	$1.22B	$1.21B	$1.19B	$1.15B	$1.18B	$1.15B	$1.13B	$1.11B	$1.08B	$1.08B	$1.09B	$1.05B	$1.12B	$1.15B	$1.18B	$1.08B	$1.09B	$1.11B	$1.22B	$1.22B	$1.13B	$1.05B	$1.02B	$996.34M	$903.91M	$715.83M
Low Forecast	$1.28B	$1.28B	$1.25B	$1.23B	$1.19B	$1.18B	$1.16B	$1.12B	$1.15B	$1.13B	$1.11B	$1.07B	$1.06B	$1.08B	$1.09B	$1.05B	$1.07B	$1.10B	$1.15B	$1.06B	$1.06B	$1.11B	$1.22B	$1.22B	$1.13B	$1.05B	$1.02B	$996.34M	$903.91M	$715.83M
# Analysts	6	4	4	6	5	4	8	5	3	3	6	9	12	6	3	3	5	13	6	6	5	5	5	11	12	11	10	9	9	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.03%	-	1.01%	1.02%	1.12%	1.00%	0.95%	1.00%	0.85%	1.06%	1.11%	1.10%	-	1.11%

Illumina's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.05B, with a low forecast of $1.05B, and a high forecast of $1.05B. ILMN's average Quarter revenue forecast represents a -6.39% decrease compared to the company's last Quarter revenue of $1.12B (Dec 23).

Illumina EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	4	4	6	5	4	8	5	3	3	6	9	12	6	3	3	5	13	6	6	5	5	5	11	12	11	10	9	9	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-164.00M	-	$-88.00M	$-64.00M	$41.00M	$4.15B	$72.00M	$237.00M	$132.00M	$-545.00M	$187.00M	$193.00M	-	$162.00M
Avg Forecast	$-66.29M	$-65.98M	$-64.50M	$-63.78M	$-61.73M	$-61.06M	$-60.06M	$-58.07M	$-59.44M	$-58.17M	$-57.19M	$-55.55M	$-54.94M	$-55.37M	$-56.04M	$232.60M	$-55.75M	$-58.02M	$-59.50M	$211.46M	$113.74M	$335.58M	$369.07M	$192.23M	$340.22M	$316.63M	$170.00M	$300.95M	$273.03M	$216.22M
High Forecast	$-65.76M	$-65.45M	$-63.98M	$-63.27M	$-61.24M	$-60.57M	$-59.58M	$-57.61M	$-58.96M	$-57.70M	$-56.74M	$-55.04M	$-54.50M	$-55.15M	$-56.01M	$279.12M	$-54.72M	$-56.55M	$-59.02M	$253.75M	$136.49M	$335.58M	$369.07M	$230.68M	$340.22M	$316.63M	$204.00M	$300.95M	$273.03M	$216.22M
Low Forecast	$-67.43M	$-67.11M	$-65.60M	$-64.87M	$-62.79M	$-62.11M	$-61.09M	$-59.07M	$-60.46M	$-59.16M	$-58.17M	$-57.11M	$-55.46M	$-55.59M	$-56.07M	$186.08M	$-57.28M	$-58.74M	$-60.52M	$169.17M	$90.99M	$335.58M	$369.07M	$153.79M	$340.22M	$316.63M	$136.00M	$300.95M	$273.03M	$216.22M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.94%	-	1.48%	-0.30%	0.36%	12.36%	0.20%	1.23%	0.39%	-1.72%	1.10%	0.64%	-	0.75%

6 analysts predict ILMN's average Quarter EBITDA for Mar 23 to be $211.46M, with a high of $253.75M and a low of $169.17M. This is 415.75% upper than Illumina's previous annual EBITDA (Dec 22) of $41.00M.

Illumina Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	4	4	6	5	4	8	5	3	3	6	9	12	6	3	3	5	13	6	6	5	5	5	11	12	11	10	9	9	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-176.00M	-	$-234.00M	$3.00M	$112.00M	$-3.82B	$-535.00M	$86.00M	$257.00M	$317.00M	$185.00M	$147.00M	-	$179.00M
Avg Forecast	$235.20M	$252.80M	$225.60M	$228.80M	$203.49M	$214.70M	$198.32M	$190.49M	$188.61M	$183.24M	$171.97M	$160.58M	$146.63M	$140.58M	$17.54M	$84.40M	$2.90M	$23.19M	$2.52M	$76.73M	$67.76M	$44.23M	$96.41M	$69.76M	$70.48M	$203.26M	$115.63M	$214.57M	$171.49M	$125.63M
High Forecast	$240.44M	$258.43M	$230.63M	$233.90M	$208.02M	$219.48M	$202.74M	$194.73M	$192.81M	$187.33M	$175.80M	$180.66M	$154.96M	$140.93M	$17.57M	$101.29M	$49.22M	$38.65M	$2.58M	$92.08M	$81.31M	$44.23M	$96.41M	$83.71M	$70.48M	$205.89M	$138.75M	$214.57M	$171.49M	$125.63M
Low Forecast	$232.75M	$250.17M	$223.25M	$226.42M	$201.37M	$212.46M	$196.25M	$188.50M	$186.65M	$181.34M	$170.18M	$140.51M	$116.64M	$140.24M	$17.50M	$67.52M	$-23.16M	$-5.80M	$2.50M	$61.38M	$54.21M	$44.23M	$96.41M	$55.80M	$70.48M	$200.63M	$92.50M	$214.57M	$171.49M	$125.63M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-60.79%	-	-92.81%	0.04%	1.65%	-86.28%	-5.55%	1.23%	3.65%	1.56%	1.60%	0.69%	-	1.42%

Illumina's average Quarter net income forecast for Jun 23 is $2.52M, with a range of $2.50M to $2.58M. ILMN's average Quarter net income forecast represents a -15.96% decrease compared to the company's last Quarter net income of $3.00M (Mar 23).

Illumina SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	4	4	6	5	4	8	5	3	3	6	9	12	6	3	3	5	13	6	6	5	5	5	11	12	11	10	9	9	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$485.00M	-	$450.00M	$378.00M	$426.00M	$146.00M	$410.00M	$308.00M	$298.00M	$879.00M	$413.00M	$374.00M	-	$192.00M
Avg Forecast	$421.33M	$419.37M	$409.92M	$405.36M	$392.35M	$388.09M	$381.76M	$369.09M	$377.79M	$369.70M	$363.51M	$353.09M	$349.20M	$351.90M	$356.18M	$302.28M	$354.32M	$368.79M	$378.15M	$274.80M	$257.73M	$356.00M	$391.53M	$249.82M	$360.93M	$335.89M	$258.13M	$319.26M	$289.64M	$229.38M
High Forecast	$428.55M	$426.56M	$416.95M	$412.31M	$399.07M	$394.74M	$388.30M	$375.41M	$384.27M	$376.04M	$369.74M	$362.99M	$352.47M	$353.29M	$356.38M	$362.74M	$364.07M	$373.33M	$384.63M	$329.77M	$309.28M	$356.00M	$391.53M	$299.79M	$360.93M	$335.89M	$309.75M	$319.26M	$289.64M	$229.38M
Low Forecast	$417.95M	$416.01M	$406.64M	$402.11M	$389.20M	$384.98M	$378.70M	$366.13M	$374.77M	$366.74M	$360.60M	$349.79M	$346.40M	$350.51M	$355.99M	$241.83M	$347.82M	$359.43M	$375.12M	$219.84M	$206.18M	$356.00M	$391.53M	$199.86M	$360.93M	$335.89M	$206.50M	$319.26M	$289.64M	$229.38M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.37%	-	1.19%	1.38%	1.65%	0.41%	1.05%	1.23%	0.83%	2.62%	1.60%	1.17%	-	0.84%

Illumina's average Quarter SG&A projection for Mar 24 is $302.28M, based on 3 Wall Street analysts, with a range of $241.83M to $362.74M. The forecast indicates a -37.67% fall compared to ILMN last annual SG&A of $485.00M (Dec 23).

Illumina EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	4	4	6	5	4	8	5	3	3	6	9	12	6	3	3	5	13	6	6	5	5	5	11	12	11	10	9	9	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-1.11	-	$-1.48	$0.02	$0.71	$-24.31	$-3.41	$0.55	$1.76	$2.09	$1.27	$1.01	-	$1.22
Avg Forecast	$1.47	$1.58	$1.41	$1.43	$1.27	$1.34	$1.24	$1.19	$1.18	$1.15	$1.07	$1.00	$0.92	$0.88	$0.11	$0.04	$0.02	$0.14	$0.02	$0.01	$0.26	$0.28	$0.61	$0.87	$0.44	$1.28	$1.32	$1.35	$1.08	$0.79
High Forecast	$1.50	$1.62	$1.44	$1.46	$1.30	$1.37	$1.27	$1.22	$1.21	$1.17	$1.10	$1.13	$0.97	$0.88	$0.11	$0.04	$0.31	$0.24	$0.02	$0.01	$0.26	$0.28	$0.61	$0.87	$0.44	$1.29	$1.32	$1.35	$1.08	$0.79
Low Forecast	$1.45	$1.56	$1.40	$1.42	$1.26	$1.33	$1.23	$1.18	$1.17	$1.13	$1.06	$0.88	$0.73	$0.88	$0.11	$0.04	$-0.14	$-0.04	$0.02	$0.01	$0.25	$0.28	$0.61	$0.87	$0.44	$1.26	$1.32	$1.35	$1.08	$0.79
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-61.34%	-	-93.92%	3.71%	2.76%	-87.39%	-5.62%	0.63%	3.97%	1.63%	0.96%	0.75%	-	1.54%

According to 6 Wall Street analysts, Illumina's projected average Quarter EPS for Jun 23 is $0.02, with a low estimate of $0.02 and a high estimate of $0.02. This represents a -21.21% decrease compared to ILMN previous annual EPS of $0.02 (Mar 23).

Illumina Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
EXAS	Exact Sciences	$49.54	$89.67	81.01%	Buy
ILMN	Illumina	$130.74	$202.44	54.84%	Buy
CDNA	CareDx	$21.56	$29.75	37.99%	Buy
DHR	Danaher	$230.06	$305.47	32.78%	Buy
TMO	Thermo Fisher Scientific	$501.29	$642.48	28.17%	Buy
A	Agilent	$126.92	$152.64	20.26%	Buy
IDXX	IDEXX Laboratories	$419.83	$479.75	14.27%	Buy
TWST	Twist Bioscience	$41.43	$42.40	2.34%	Buy
WAT	Waters	$355.47	$356.80	0.37%	Buy
NTRA	Natera	$153.42	$120.92	-21.18%	Buy

ILMN Forecast FAQ

Is Illumina a good buy?

Yes, according to 22 Wall Street analysts, Illumina (ILMN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 16 'Buy' recommendations, accounting for 72.73% of ILMN's total ratings.

What is ILMN's price target?

Illumina (ILMN) average price target is $202.44 with a range of $58 to $562, implying a 54.84% from its last price of $130.74. The data is based on 22 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Illumina stock go up soon?

According to Wall Street analysts' prediction for ILMN stock, the company can go up by 54.84% (from the last price of $130.74 to the average price target of $202.44), up by 329.86% based on the highest stock price target, and down by -55.64% based on the lowest stock price target.

Can Illumina stock reach $200?

ILMN's average twelve months analyst stock price target of $202.44 supports the claim that Illumina can reach $200 in the near future.

What is Illumina's current price target trend?

3 Wall Street analysts forecast a $143 price target for Illumina (ILMN) this month, up 9.38% from its last price of $130.74. Compared to the last 3 and 12 months, the average price target increased by 16.11% and increased by 14.43%, respectively.

What are Illumina's analysts' financial forecasts?

Illumina's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.7B (high $4.78B, low $4.66B), average EBITDA is $-241M (high $-239M, low $-245M), average net income is $807M (high $824.97M, low $798.59M), average SG&A $1.53B (high $1.56B, low $1.52B), and average EPS is $5.04 (high $5.16, low $4.99). ILMN's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $5.08B (high $5.17B, low $5.04B), average EBITDA is $-261M (high $-258M, low $-265M), average net income is $942.4M (high $963.39M, low $932.58M), average SG&A $1.66B (high $1.68B, low $1.64B), and average EPS is $5.89 (high $6.02, low $5.83).

Did the ILMN's actual financial results beat the analysts' financial forecasts?

Based on Illumina's last annual report (Dec 2023), the company's revenue was $4.58B, beating the average analysts forecast of $4.45B by 3.11%. Apple's EBITDA was $4.89B, beating the average prediction of $38.19M by 12697.53%. The company's net income was $-4.404B, missing the average estimation of $105.34M by -4280.88%. Apple's SG&A was $1.3B, missing the average forecast of $1.38B by -5.75%. Lastly, the company's EPS was $-28.05, missing the average prediction of $0.184 by -15330.00%. In terms of the last quarterly report (Dec 2023), Illumina's revenue was $1.12B, beating the average analysts' forecast of $1.09B by 3.19%. The company's EBITDA was $-164M, beating the average prediction of $-55.748M by 194.18%. Illumina's net income was $-176M, missing the average estimation of $2.9M by -6178.69%. The company's SG&A was $485M, beating the average forecast of $354.32M by 36.88%. Lastly, the company's EPS was $-1.11, missing the average prediction of $0.0181 by -6233.95%